Iván Domenzain

Iván Domenzain

Auto-generated profile, based on publicly available information

Iván Domenzain

Department of Life Sciences, Chalmers University of Technology

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 March 2020 in Science Signaling
Verified
Journal Article
Closed access
PDF file
JRJonathan L. Robinson
Jonathan L. Robinson
PKPINAR KOCABAŞ
PINAR KOCABAŞ
HWHao Wang
Hao Wang
PCPierre-Etienne Cholley
Pierre-Etienne Cholley
DCDaniel Cook
Daniel Cook
JNJens Nielsen
Jens Nielsen
An open-source, genome-scale human metabolic model and a web portal to explore the model are generated.

18 October 2018 in PLOS Computational Biology
Verified
Journal Article
Open access
PDF file
HWHao Wang
Hao Wang
SMSimonas Marcišauskas
Simonas Marcišauskas
BSBenjamín J Sánchez
Benjamín J Sánchez
IDIván Domenzain
Iván Domenzain
DHDaniel Hermansson
Daniel Hermansson
EKEduard Kerkhoven
Eduard Kerkhoven
RAVEN is a commonly used MATLAB toolbox for genome-scale metabolic model (GEM) reconstruction, curation and constraint-based modelling and simulation. Here we present RAVEN Toolbox 2.0 with major enhancements, including: (i) de novo reconstruction of GEMs based on the MetaCyc pathway database; (ii) a redesigned KEGG-based reconstruction pipeline; (iii) convergence of reconstructions from various sources; (iv) improved performance, usability, and compatibility with the COBRA Toolbox. Capabilities of RAVEN 2.0 are here illustrated through de novo reconstruction of GEMs for the antibiotic-producing bacterium Streptomyces coelicolor. Comparison of the automated de novo reconstructions with the iMK1208 model, a previously published high-quality S. coelicolor GEM, exemplifies that RAVEN 2.0 can capture most of the manually curated model. The generated de novo reconstruction is subsequently used to curate iMK1208 resulting in Sco4, the most comprehensive GEM of S. coelicolor, with increased coverage of both primary and secondary metabolism. This increased coverage allows the use of Sco4 to predict novel genome editing targets for optimized secondary metabolites production. As such, we demonstrate that RAVEN 2.0 can be used not only for de novo GEM reconstruction, but also for curating existing models based on up-to-date databases. Both RAVEN 2.0 and Sco4 are distributed through GitHub to facilitate usage and further development by the community (https://github.com/SysBioChalmers/RAVEN and https://github.com/SysBioChalmers/Streptomyces_coelicolor-GEM). Cellular metabolism is a large and complex network. Hence, investigations of metabolic networks are aided by in silico modelling and simulations. Metabolic networks can be derived from whole-genome sequences, through identifying what enzymes are present and connecting these to formalized chemical reactions. To facilitate the reconstruction of genome-scale models of metabolism (GEMs), we have developed RAVEN 2.0. This versatile toolbox can reconstruct GEMs fast, through either metabolic pathway databases KEGG and MetaCyc, or from homology with an existing GEM. We demonstrate RAVEN's functionality through generation of a metabolic model of Streptomyces coelicolor, an antibiotic-producing bacterium. Comparison of this de novo generated GEM with a previously manually curated model demonstrates that RAVEN captures most of the previous model, and we subsequently reconstructed an updated model of S. coelicolor: Sco4. Following, we used Sco4 to predict promising targets for genetic engineering, which can be used to increase antibiotic production.

8 August 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
HLHongzhong Lu
Hongzhong Lu
FLFeiran Li
Feiran Li
BSBenjamín J. Sánchez
Benjamín J. Sánchez
ZZZhengming Zhu
Zhengming Zhu
GLGang Li
Gang Li
JNJens Nielsen
Jens Nielsen
Genome-scale metabolic models (GEMs) represent extensive knowledgebases that provide a platform for model simulations and integrative analysis of omics data. This study introduces Yeast8 and an associated ecosystem of models that represent a comprehensive computational resource for performing simulations of the metabolism ofSaccharomyces cerevisiae––an important model organism and widely used cell-factory. Yeast8 tracks community development with version control, setting a standard for how GEMs can be continuously updated in a simple and reproducible way. We use Yeast8 to develop the derived models panYeast8 and coreYeast8, which in turn enable the reconstruction of GEMs for 1,011 different yeast strains. Through integration with enzyme constraints (ecYeast8) and protein 3D structures (proYeast8DB), Yeast8 further facilitates the exploration of yeast metabolism at a multi-scale level, enabling prediction of how single nucleotide variations translate to phenotypic traits.

30 June 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
IDIván Domenzain
Iván Domenzain
BSBenjamín Sánchez
Benjamín Sánchez
MAMihail Anton
Mihail Anton
EKEduard Kerkhoven
Eduard Kerkhoven
AMAarón Millán-Oropeza
Aarón Millán-Oropeza
JNJens Nielsen
Jens Nielsen
Genome-scale metabolic models (GEMs) have been widely used for quantitative exploration of the relation between genotype and phenotype. Streamlined integration of enzyme constraints and proteomics data into such models was first enabled by the GECKO toolbox, allowing the study of phenotypes constrained by protein limitations. Here, we upgrade the toolbox in order to enhance models with enzyme and proteomics constraints for any organism with a compatible GEM reconstruction. With this, enzyme-constrained models for the budding yeasts Saccharomyces cerevisiae, Yarrowia lipolytica and Kluyveromyces marxianus are generated to study their long-term adaptation to several stress factors by incorporation of proteomics data. Predictions reveal that upregulation and high saturation of enzymes in amino acid metabolism are common across organisms and conditions, suggesting the relevance of metabolic robustness in contrast to optimal protein utilization as a cellular objective for microbial growth under stress and nutrient-limited conditions. The functionality of GECKO is expanded with an automated framework for continuous and version-controlled update of enzyme-constrained GEMs, also producing such models for Escherichia coli and Homo sapiens. In this work, we facilitate the utilization of enzyme-constrained GEMs in basic science, metabolic engineering and synthetic biology purposes.

18 January 2024 in Nature Protocols
Verified
Journal Article
Closed access
PDF file
YCYu Chen
Yu Chen
JGJohan Gustafsson
Johan Gustafsson
ARAlbert Tafur Rangel
Albert Tafur Rangel
MAMihail Anton
Mihail Anton
IDIván Domenzain
Iván Domenzain
EKEduard Kerkhoven
Eduard Kerkhoven

18 July 2022 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
OIOlena Ishchuk
Olena Ishchuk
IDIván Domenzain
Iván Domenzain
BSBenjamín J. Sánchez
Benjamín J. Sánchez
FMFacundo Rafael Muñiz-Paredes
Facundo Rafael Muñiz-Paredes
JMJosé Luis Martinez
José Luis Martinez
DPDina Petranovic
Dina Petranovic
Heme is an oxygen carrier and a cofactor of both industrial enzymes and food additives. The intracellular level of free heme is low, which limits the synthesis of heme proteins. Therefore, increasing heme synthesis allows an increased production of heme proteins. Using the genome-scale metabolic model (GEM) Yeast8 for the yeast Saccharomyces cerevisiae , we identified fluxes potentially important to heme synthesis. With this model, in silico simulations highlighted 84 gene targets for balancing biomass and increasing heme production. Of those identified, 76 genes were individually deleted or overexpressed in experiments. Empirically, 40 genes individually increased heme production (up to threefold). Heme was increased by modifying target genes, which not only included the genes involved in heme biosynthesis, but also those involved in glycolysis, pyruvate, Fe-S clusters, glycine, and succinyl-coenzyme A (CoA) metabolism. Next, we developed an algorithmic method for predicting an optimal combination of these genes by using the enzyme-constrained extension of the Yeast8 model, ecYeast8. The computationally identified combination for enhanced heme production was evaluated using the heme ligand-binding biosensor (Heme-LBB). The positive targets were combined using CRISPR-Cas9 in the yeast strain (IMX581- HEM15-HEM14-HEM3-Δshm1-HEM2-Δhmx1-FET4-Δgcv2-HEM1-Δgcv1-HEM13 ), which produces 70-fold-higher levels of intracellular heme.